Regulation 2 Amendment of regulation 2 of the Pharmaceutical Services Regulations
Regulation 2(1) of the Pharmaceutical Services Regulationsf1 (interpretation) is amended as follows.
At the appropriate places insert—
““serious shortage protocol” (“protocol prinder difrifol”) means—
- (a)
in the case of a prescription only medicine, a serious shortage protocol for the purposes of regulation 226A of the Human Medicines Regulations 2012f2 (sale etc. by a pharmacist in accordance with a serious shortage protocol); or
- (b)
in the case of any other drug or appliance, a written protocol that—
- (i)
is issued by the Welsh Ministers in circumstances where Wales or any part of Wales is, in the opinion of the Welsh Ministers, experiencing or may experience a serious shortage of—
- (aa)
a specified drug or appliance, or
- (bb)
drugs or appliances of a specified description,
- (ii)
provides for the supply by an NHS pharmacist or an NHS appliance contractor providing pharmaceutical or local pharmaceutical services, where there is an order on a prescription form or a repeatable prescription for—
- (aa)
the specified drug or appliance, or
- (bb)
a drug or appliance of the specified description,
of a different product or quantity of product to the product or quantity of product ordered, subject to such conditions as may be specified in the protocol, and
- (iii)
specifies the period for which, and the parts of Wales (which may be all of Wales) in which, the protocol is to have effect;”, and
““SSP” (“PPD”) means a serious shortage protocol;”.
Annotations
Footnotes
- f1
-
Regulation 2 has been amended by S.I. 2014/2291 (W. 226), S.I. 2016/696, S.I. 2016/1221 (W. 292) and S.I. 2019/149 (W. 34), It is prospectively amended by S.I. 2019/1094.
- f2
-
S.I. 2012/1916; regulation 226A was inserted by S.I. 2019/62.